Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Sangro

Showing results (11-20 of 329) with videos related to

Pageof 33
Sort By:
Hepatology (Baltimore, Md.)|July 10, 2021
Selective Internal Radiation Therapy Approval for Early HCC: What Comes Next?Mercedes Iñarrairaegui, Bruno Sangro
Current Opinion in Molecular Therapeutics|October 2, 2010
Gene therapy for liver cancer: clinical experience and future prospectsBruno Sangro, Jesus Prieto
Hepatology (Baltimore, Md.)|May 1, 2022
Immunotherapy in HCC-No rush despite the hypeBruno Sangro, Josepmaria Argemí
Gastroenterologia Y Hepatologia|October 24, 2007
[Diagnosis of small hepatocellular carcinoma]Mercedes Iñarrairaegui, Bruno Sangro
Seminars in Liver Disease|November 5, 2014
Transarterial chemoembolization and radioembolizationBruno Sangro, Riad Salem
Lancet (London, England)|October 4, 2025
Unexplained early deaths in EMERALD-1: is liver failure the reason? - Authors' replyBruno Sangro, Stephen L Chan
Current Oncology Reports|February 4, 2014
Nonsurgical treatment for localized hepatocellular carcinomaAndrew S Kennedy, Bruno Sangro
Journal of Hepatology|September 20, 2017
Targets for immunotherapy of liver cancerTim F Greten, Bruno Sangro
Gastroenterologia Y Hepatologia|October 29, 2013
[Liver enzyme elevation secondary to macroenzymes: macro-GOT]Diego Martinez-Urbistondo, Bruno Sangro
Gastroenterology|July 30, 2002
New strategies to enhance gene therapy efficiencyCheng Qian, Bruno Sangro, Jesús Prieto
Pageof 33

Showing results (11-20 of 329) with videos related to

Sort By:
Pageof 33
Hepatology (Baltimore, Md.)|July 10, 2021
Selective Internal Radiation Therapy Approval for Early HCC: What Comes Next?Mercedes Iñarrairaegui, Bruno Sangro
Current Opinion in Molecular Therapeutics|October 2, 2010
Gene therapy for liver cancer: clinical experience and future prospectsBruno Sangro, Jesus Prieto
Hepatology (Baltimore, Md.)|May 1, 2022
Immunotherapy in HCC-No rush despite the hypeBruno Sangro, Josepmaria Argemí
Gastroenterologia Y Hepatologia|October 24, 2007
[Diagnosis of small hepatocellular carcinoma]Mercedes Iñarrairaegui, Bruno Sangro
Seminars in Liver Disease|November 5, 2014
Transarterial chemoembolization and radioembolizationBruno Sangro, Riad Salem
Lancet (London, England)|October 4, 2025
Unexplained early deaths in EMERALD-1: is liver failure the reason? - Authors' replyBruno Sangro, Stephen L Chan
Current Oncology Reports|February 4, 2014
Nonsurgical treatment for localized hepatocellular carcinomaAndrew S Kennedy, Bruno Sangro
Journal of Hepatology|September 20, 2017
Targets for immunotherapy of liver cancerTim F Greten, Bruno Sangro
Gastroenterologia Y Hepatologia|October 29, 2013
[Liver enzyme elevation secondary to macroenzymes: macro-GOT]Diego Martinez-Urbistondo, Bruno Sangro
Gastroenterology|July 30, 2002
New strategies to enhance gene therapy efficiencyCheng Qian, Bruno Sangro, Jesús Prieto
Pageof 33